Nexvet Biopharma plc (NASDAQ:NVET)’s Basic Consolidated EPS Came In At $-2.2736

0

The annual basic consolidated EPS for Nexvet Biopharma plc (NASDAQ:NVET) posted annual basic consolidated EPS of $-2.2736 for the year period ended2015-06-30. But basic consolidated EPS for the quarter period ended 2015-06-30 came in at $-2.2736.

What About EPS from continuing operations

Nexvet Biopharma plc (NASDAQ:NVET)’s EPS from continuing operations for the annual period ended 2015-06-30 came in at -2.2736. On quarterly basis, EPS from continuing operations stood at $-2.2736 for the three-month period ended 2015-06-30.

EPS contribution from parent

Nexvet Biopharma plc (NASDAQ:NVET) received of $-2.2736 EPS boost from the parent company for the annual period ended 2015-06-30. For the quarter period ended 2015-06-30, the company received EPS boost of $-2.2736 from its parent company.

What About Basic net EPS

The company’s basic net EPS for the annual period ended 2015-06-30 was$-2.27, but for the quarter period ended 2015-06-30 the basic net EPS was $-2.27.

What About Consolidated Diluted EPS?

Nexvet Biopharma plc (NASDAQ:NVET) posted consolidated diluted EPS of $-2.2736 for the annual period ended 2015-06-30. On the other hand, consolidated diluted EPS for the quarterly period ended 2015-06-30 stood at $-2.2736.

Basic diluted EPS

The company’s diluted EPS from continuing operation stood at $-2.2736 for the annual period ended 2015-06-30. On quarter basis, diluted EPS from continuing operations was $-2.2736 for the three-month period ended 2015-06-30.

Net diluted EPS

Nexvet Biopharma plc (NASDAQ:NVET) posted net diluted EPS of $-2.27for the annual period ended 2015-06-30. On the other hand, it posted net diluted EPS of $-2.27 for thequarterly period ended 2015-06-30.

What portion of diluted EPS came from parent?

For the annual period ended 2015-06-30, the parent company of Nexvet Biopharma plc (NASDAQ:NVET) contributed diluted EPS of $-2.2736. The diluted EPS contribution from the parent for the quarter ended 2015-06-30 stood at $-2.2736.

The company’s net basic EPS for the annual period ended 2015-06-30 was $-2.27 while for the quarter period ended 2015-06-30 it was $-2.27.

Nexvet Biopharma plc (NASDAQ:NVET) had average basic shares outstanding of 5.215 for the annual period ended 2015-06-30 and 5.215 for the quarter period ended 2015-06-30.The number of diluted shares outstanding was 5.215 for the annual period ended 2015-06-30 and 5.215 for the quarter ended 2015-06-30.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 35 times, 1 visits today)